Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients
SMARCA4 is the core catalytic subunit of the mammalian SWI/SNF complex and is known to be mutated in many cancers. Here, the authors detect more than 10,000 SMARCA4 variants across different cancer subtypes and find hotspot mutations throughout the helicase domain, which reduce remodeling activity.
Saved in:
Main Authors: | Tharu M. Fernando, Robert Piskol, Russell Bainer, Ethan S. Sokol, Sally E. Trabucco, Qing Zhang, Huong Trinh, Sophia Maund, Marc Kschonsak, Subhra Chaudhuri, Zora Modrusan, Thomas Januario, Robert L. Yauch |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/660128134d924fbaad6dcc27af8cef1f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acta Nº668
by: Banco Central de Chile
Published: (2019) -
Resolution 668(XXXIV) Statistical Conference of the Americas of the Economic Commission for Latin America and the Caribbean
Published: (2014) -
Acta No. 131
by: Banco Central de Chile
Published: (2019) -
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
by: Katharina Leitner, et al.
Published: (2020) -
BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4
by: Hae In Choi, et al.
Published: (2021)